5'-AGCTGACCGGCAGCAAAATTGGGAGGCCATGAACAACCTTA-3' GALNT6F 5'-GGAGGCCATGAACAACCTTA-3' GALNT6R 5'-GTCTCCCCACAAGGACTCTG-3' MISEQT6F 5'-AGCTGACCGGCAGCAAAATTGTCCAAATCAGGGCTCCAGAA-3' MISEQT6R 5'-GGCAAAGGCATTGAAACAGTG-3'
*FAMFOR extension is underlined and represents a modified design previously described (20) . Species specificity of the primers is indicated with; h for human, c for CHO and m for mouse ^"Off target" primers and amplification primers listed have been designed using Primer3 software(23). Tri-allelic K562 KRAS CRISPR/Cas9 targeting evaluated by IDAA: Tri-allelic K562 KRAS gene was targeted using a plamsid expressing Cas9-2A-GFP and KRAS gRNA as previously described (14) and indels were detected after 3 consecutive rounds KRAS CRISPR/Cas9 targeting followed by FACS sorting of GFP positive cells, cell expansion and re-transfection (1 st , 2 nd and 3 rd hit of cells). Panel a: IDAA result of 1 st , 2 nd and 3 rd rounds of transfected cells day 2 post transfection. Untransfected cell control is shown in upper panel. The appearance of an unspecific minor peak observed in this assay is indicated by an asterix. The position of the wt peak is indicated by filled arrow heads. Notably the wt peak is significantly diminished after the 3 rd hit. 
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